经中国证券监督管理委员会《关于同意技源集团股份有限公司首次公开发行股 票注册的批复》（证监许可〔2025〕799 号）同意注册，并经上海证券交易所同意， 公司向社会公开发行人民币普通股（A 股）5,001.00 万股，发行价格为 10.88 元/股， 本次发行募集资金总额为 54,410.88 万元，扣除发行费用 6,429.06 万元（不含增值税） 后，募集资金净额为 47,981.82 万元。立信会计师事务所（特殊普通合伙）对公司本 次公开发行新股的资金到位情况进行了审验并出具了《验资报告》 （信会师报字[2025] 第 ZK10290 号）。公司已对上述募集资金进行专户存储管理，并已与保荐机构、募 集资金专户监管银行签订募集资金监管协议。 二、募集资金投资项目情况 证券代码：603262 证券简称：技源集团 公告编号：2025-003 技源集团股份有限公司 关于调整部分募投项目金额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 单位：万元 调整前拟投入 调整后拟投入 序号 项目名称 项目总投 ...

证券代码：603262 证券简称：技源集团 公告编号：2025-002 技源集团股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 技源集团股份有限公司（以下简称"公司"）第二届监事会第三次会议通知和 文件于 2025 年 8 月 8 日以电话、邮件方式送达公司全体监事，会议于 2025 年 8 月 实际出席监事 3 人。会议由监事会主席黄靓女士召集并主持。本次会议的召集、召 开及表决程序符合《中华人民共和国公司法》等法律、法规、规范性文件以及《公 司章程》的有关规定。 二、监事会会议审议情况 监事会认为：公司本次对募投项目拟使用募集资金金额的调整是基于募集资金 净额低于原计划投入募投项目中募集资金金额的实际情况，并为保证募投项目的顺 利实施和募集资金的高效使用所做出的决策。本次调整不会对募集资金的正常使用 造成实质性影响，不存在改变或变相改变募集资金用途和损害股东利益的情况。本 次调整符合中国证监会、上海证券交易所关于上市公司募集资金管理的有关规定， 有利于提高公司资金使用效率，优化资 ...

Core Points - The company, 技源集团, has adjusted the amount allocated for certain fundraising projects due to the actual net fundraising amount being lower than initially planned [1][2] - The total amount raised through the public offering was 54,410.88 million RMB, with a net amount of 47,981.82 million RMB after deducting issuance costs [1][2] - The adjustment aims to ensure the smooth implementation of fundraising projects and efficient use of funds without changing the intended use of the raised funds [2][4] Fundraising Basic Situation - The company was approved by the China Securities Regulatory Commission for its initial public offering, issuing 50.01 million shares at a price of 10.88 RMB per share [1] - The total planned investment amount disclosed in the prospectus was 60,272.93 million RMB, which exceeds the actual net amount raised [2] Adjustment of Fundraising Investment Projects - The company plans to adjust the amount allocated to the working capital project while maintaining the total investment amount of 60,272.93 million RMB [2] - The adjustment is necessary to align with the actual net fundraising amount of 47,981.82 million RMB [2] Impact of the Adjustment - The adjustment will not materially affect the normal use of the raised funds and does not change the intended use or harm shareholder interests [3][4] - The decision aligns with the regulations set by the China Securities Regulatory Commission and the Shanghai Stock Exchange, supporting the company's future development strategy [4] Review Procedures - The adjustment was approved by the company's board of directors and supervisory board, following necessary approval procedures [3][4] - The supervisory board supports the adjustment, emphasizing its necessity for efficient fund usage and project implementation [3][4] Sponsor's Verification Opinion - The sponsor, 东方证券, confirms that the adjustment complies with relevant regulations and does not harm the interests of the company or its shareholders [4]

证券代码：688798 证券简称：艾为电子 公告编号：2025-039 上海艾为电子技术股份有限公司 第四届监事会第十二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 （1）2025 年半年度报告的编制和审议程序符合法律、法规、《公司章程》 和公司内部管理制度的规定； （2）2025 年半年度报告的内容和格式符合中国证监会和上海证券交易所的 各项规定，所包含的信息能从各个方面真实、公允、客观地反映出公司 2025 年 半年度经营管理和财务状况等事项； 上海艾为电子技术股份有限公司（以下简称"公司"）第四届监事会第十二次 会议于 2025 年 8 月 12 日在公司会议室以现场结合通讯方式召开，本次会议通知 及相关材料已于 2025 年 8 月 2 日以邮件、电话或其他通讯方式送达至公司全体 监事。会议由监事会主席吴绍夫先生召集并主持，应出席监事 3 名，实际出席 3 名，会议的召开符合有关法律、法规、规章和《上海艾为电子技术股份有限公司 章程》（以下简称"《公司章程》"）的规定，会议 ...

证券代码：688798 证券简称：艾为电子 公告编号：2025-041 上海艾为电子技术股份有限公司 关于继续使用部分闲置募集资金暂时补充流动资金 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 为电子技术股份有限公司首次公开发行股票注册的批复》 号），公司首次向社会公开发行人民币普通股（A）股 4,180 万股，每股发行价格 为 76.58 元，募集资金总额为人民币 3,201,044,000 元；扣除发行费用后实际募集 资金净额为人民币 3,035,261,414.64 元。上述募集资金已于 2021 年 8 月 10 日全 部到账并经大信会计师事务所（特殊普通合伙）对公司首次公开发行股票的资金 到位情况进行了审验，并于 2021 年 8 月 10 日出具了大信验字【2021】第 4-00042 号《验资报告》。 "艾 为电子"或"本公司"）召开第四届董事会第十三次会议和第四届监事会第十二 次会议，审议通过了《关于继续使用部分闲置募集资金暂时补充流动资金的议案》， 同意公司继续使用不超过人民币 40,000 万 ...

Fundraising Overview - The actual net amount raised after deducting underwriting fees was RMB 3,035,261,414.64, with the funds deposited in the designated bank account on August 10, 2021 [1] - As of June 30, 2025, the company had used a total of RMB 2,165,506,830.13 of the raised funds, with a remaining balance of RMB 163,051,907.75 [1][3] Fund Usage and Management - The company has established a management system for the use of raised funds, which was updated multiple times, with the latest update approved on February 5, 2024 [1] - The company has used RMB 338,271,818.13 of the raised funds in the current year, with no prior year usage reported for this period [1][7] - The company temporarily used RMB 60 million of idle raised funds to supplement working capital, which was fully returned by August 8, 2025 [3] Investment Projects - The company has not made any early investments or replacements for the fundraising projects during the reporting period [3][5] - The company has approved the use of idle funds for cash management, with a total of RMB 250 million allocated to various financial products [4][5] Changes in Fundraising Projects - The company has not used any excess funds for permanent working capital or loan repayments during the reporting period [5][6] - There were no instances of surplus funds being used, and the company has not reported any changes in the feasibility of projects [5][8] Project Implementation and Adjustments - The company has added several subsidiaries as implementation entities for various fundraising projects, including smart audio chip development and 5G RF device development [6] - The company has made adjustments to project timelines and funding allocations due to changes in market conditions and strategic planning [8][9]

证券代码：688620 证券简称：安凯微 公告编号：2025-047 广州安凯微电子股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证监会《上市公司募集资金监管规则》和上海证券交易所印发的《上 海证券交易所科创板上市公司自律监管指引第1号——规范运作（2025年5月修订）》 （上证发〔2025〕68号）及《广州安凯微电子股份有限公司募集资金管理制度》 （以下简称"《募集资金管理制度》"）的相关规定，广州安凯微电子股份有限公 司（以下简称"公司"）董事会编制了《2025年半年度募集资金存放与实际使用情 况的专项报告》，报告详情如下： 一、募集资金基本情况 注：上表中数据如存在尾差，系因四舍五入所致。 二、募集资金存放和管理情况 （一）募集资金的管理情况 （一）实际募集资金金额和资金到位时间 经上海证券交易所科创板上市委2023年第7次审议会议审议通过和中国证券监督 管理委员会《关于同意广州安凯微电子股份有限公司首次公开发行股票注册的批复》 （证监许可〔2023〕1000号）同意注册，公司首次公开发行股票 ...

Summary of Key Points Core Viewpoint - Haichuang Pharmaceutical Co., Ltd. has provided a detailed report on the management and usage of raised funds as of June 30, 2025, highlighting the total amount raised, its allocation, and the management protocols in place to ensure compliance and security of the funds [1][2]. Fundraising Overview - The company raised a total of RMB 1,062,699,200.00 through the issuance of 24,760,000 shares at RMB 42.92 per share, with a net amount of RMB 995,113,315.68 after deducting issuance costs [1][2]. - As of June 30, 2025, the cumulative usage of the raised funds amounted to RMB 871,447,067.89, leaving a balance of RMB 147,244,678.39, which includes RMB 23,578,430.60 from cash management [1][2]. Fund Management Practices - The company has established a fundraising management system to regulate the storage, management, and usage of the raised funds, ensuring compliance with relevant regulations [1][2]. - A tripartite supervision agreement has been signed with the underwriter and banks to clarify the rights and obligations of all parties involved in the management of the funds [1][2]. Actual Usage of Funds - The report indicates that there were no instances of using raised funds to replace pre-invested amounts or to temporarily supplement working capital during the reporting period [2][3]. - The company has approved the use of up to RMB 170 million of temporarily idle funds for cash management, investing in high-security and liquid financial products [2][3]. Project Delays and Adjustments - The company has postponed the completion date for certain fundraising projects, including the "R&D Production Base Construction Project" to December 31, 2025, and parts of the "Innovative Drug R&D Project" to December 31, 2026, due to implementation progress considerations [2][3]. - No changes have been made to the investment projects or their total amounts, ensuring that the adjustments do not adversely affect the company's operations or shareholder interests [3][4].

Group 1 - The company approved the temporary use of idle raised funds amounting to no more than RMB 20 million to supplement working capital, which will be used for business-related production and operational expenses [1] - The duration for the use of these funds is set to not exceed 12 months from the date of board approval [1] - As of the date of the announcement, the company has fully returned the RMB 20 million used for temporary working capital back to the designated special account for raised funds [1] Group 2 - The returned funds are associated with the project "Ecological Protection and Environmental Governance R&D Capability Enhancement Project" [1]

广州安凯微电子股份有限公司 募集资金管理制度 第一章 总则 第一条 为了规范广州安凯微电子股份有限公司（以下简称"公司"）的募 集资金的使用与管理，根据《中华人民共和国公司法》《中华人民共和国证券法》 《上海证券交易所科创板股票上市规则》（以下简称"《股票上市规则》"）、 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上市公 司募集资金监管规则》等规范性文件及《广州安凯微电子股份有限公司章程》 （以 下简称"《公司章程》"）等有关规定，结合公司实际情况，制定本制度。 第二条 本制度称募集资金，是指公司通过向不特定对象发行证券（包括首 次公开发行股票、配股、增发、发行可转换公司债券、发行分离交易的可转换公 司债券等）以及向特定对象发行证券募集的资金，但不包括公司实施股权激励计 划募集的资金。 第三条 公司应当建立并完善募集资金存储、使用、变更、监督和责任追究 的制度，明确募集资金使用的分级审批权限、决策程序、风险控制措施及信息披 露要求，保证募集资金项目的正常进行。 第四条 公司董事会应当对募集资金投资项目的可行性进行充分论证，确信 投资项目具有较好的市场前景和盈利能力，有效防范投资风险， ...